|
Biospecimen_Type
|
Biospecimen_Type |
|
|
nitroglycerin
|
nitroglycerin |
|
|
Vilanterol und Umeclidiniumbromid
|
R03AL03 |
|
|
Salbutamol und Ipratropiumbromid
|
R03AL02 |
|
|
Fenoterol und Ipratropiumbromid
|
R03AL01 |
|
|
Glucose:SCnc:Pt:Synv_fld:Qn
|
Glucose:SCnc:Pt:Synv_fld:Qn |
|
|
Formoterol und Glycopyrroniumbromid
|
R03AL07 |
|
|
Ascitic_fluid_protein_measurement
|
Ascitic_fluid_protein_measurement |
|
|
Olodaterol und Tiotropiumbromid
|
R03AL06 |
|
|
Formoterol und Aclidiniumbromid
|
R03AL05 |
|
|
Indacaterol und Glycopyrroniumbromid
|
R03AL04 |
|
|
Start_of_apheresis_therapy
|
Start_of_apheresis_therapy |
|
|
Treatment_initiated_in_disease_phase
|
Treatment_initiated_in_disease_phase |
|
|
Magnetic_Field_Strength
|
Magnetic_Field_Strength |
|
|
Phosphate_(Body_fld)_[Mass/Vol]
|
Phosphate_(Body_fld)_[Mass/Vol] |
|
|
How_many_times_has_the_patient_sought_other_health_care_type?
|
How_many_times_has_the_patient_sought_other_health_care_type? |
|
|
Formoterol Glycopyrroniumbromid und Beclometason
|
R03AL09 |
|
|
Whole_body_wash
|
Whole_body_wash |
|
|
Vilanterol Umeclidiniumbromid und Fluticasonfuroat
|
R03AL08 |
|
|
CD4-positive_T-lymphocyte_count
|
CD4-positive_T-lymphocyte_count |
|
